Navigation Links
SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
Date:2/25/2008

DUBLIN, Calif., Feb. 25 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2007 fourth quarter and fiscal year-end financial results on Monday, Mar. 3, 2008. SuperGen Management will provide details of the Company's financial results, and provide financial guidance for fiscal year-end 2008.

A press release will be transmitted to the news media immediately following the close of the market on Mar. 3, 2008. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast is accessible via the investor relations section of the Company's Web site at http://www.supergen.com. A webcast replay of the live conference call will be available for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

Contacts:

SuperGen SuperGen

Timothy L. Enns Mary M. Vegh

S.V.P., Corporate Communications Manager, Investor Relations

& Business Development (925) 560-2845

(925) 560-0100 x111 mary.vegh@supergen.com

tenns@supergen.com


'/>"/>
SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
2. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
3. Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
4. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
5. Aton Pharma Announces the Appointment of Dr. Fred Eshelman to Management Board
6. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
7. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
8. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
9. Masimo Announces Continuous Noninvasive Total Hemoglobin
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... NY (PRWEB) , ... August 14, 2017 , ... ... Clinical Trials event, which will take place on September 6, 2017 at the ... Karlin, MD , Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer Innovative Research ...
(Date:8/11/2017)... ... 11, 2017 , ... A staple in the community for more than 60 ... key elements including a new digital marketing strategy and updated logo. , As part ... has partnered with the South Texas Blood & Tissue Center for the month of ...
(Date:8/11/2017)... ... August 11, 2017 , ... ... and, in particular, more natural alternatives to synthetic ingredients,” said Matt Hundt, President ... Wave, with the established manufacturing presence and know-how of Biorigin will allow us ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... week-- as students. From August 14th through the 16th, the University City Science ... in the summer of 2016, provides Philadelphia-based middle school educators an opportunity for ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
Breaking Biology News(10 mins):